Scientists hunt for better ways to spot hidden adrenal tumors

NCT ID NCT00004847

Recruiting now Knowledge-focused Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 05, 2026 · Updated 8 times

Summary

This study aims to improve how doctors find and understand pheochromocytomas and paragangliomas, rare tumors that can cause dangerous high blood pressure. Researchers will use advanced imaging scans and genetic testing in up to 3,000 participants to learn more about these tumors. The goal is to develop better diagnostic methods and explore potential future treatments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: radioactive tracers ([18F]-DOPA, [18F]-DA, [68Ga]-DOTATATE) for PET scans
What this could lead to: If successful, this research could lead to better ways to detect and understand these rare tumors, potentially improving treatment options in the future.
What could go wrong: This is an early-phase observational study focused on gathering knowledge, not testing a new treatment. It may not directly benefit participants or lead to immediate clinical changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ENDOCRINE DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

endocrine system disorder paraganglioma pheochromocytoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ENDOCRINE DISEASE ENDOCRINE DISEASES PHEOCHROMOCYTOMA

Contacts and locations

Locations

National Institutes of Health Clinical Center
RECRUITING

Bethesda, Maryland, 20892, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.